STAAR Surgical Company
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -32.2% | -148.0% | – | -83.2% | -993.1% | – | – | -246.8% | – | – | – | |
| – | +1.7% | -9.4% | +23.0% | +15.4% | +35.2% | -1.6% | -15.5% | +1.3% | +20.8% | -8.5% | +51.0% | – | |
| – | -97.9% | +3,383.0% | +42.6% | -20.8% | -34.8% | +28.8% | +29.7% | +4.6% | +5.6% | -44.0% | +36.0% | – | |
| – | – | -17.8% | -275.4% | – | – | +14.9% | -154.0% | – | – | -4,719.9% | – | – | |
| – | -66.4% | +68.5% | +19.9% | -0.1% | -8.1% | -74.4% | +22.1% | -50.7% | +89.9% | -73.6% | +11.5% | – | |
| – | -29.6% | -27.7% | -227.7% | +70.5% | -44.7% | – | -28.9% | -79.0% | -467.5% | – | -163.6% | – | |
| – | +20.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,772.3% | -41.4% | -86.4% | -100.0% | – | +1,077.1% | +249.1% | -55.7% | -91.7% | +1,038.4% | +46.8% | – | |
| – | – | – | – | – | -2.4% | +2.4% | -100.0% | – | – | – | – | – | |
| – | -94.8% | +1,005.2% | -96.0% | +890.8% | -106.8% | +761.8% | +378.9% | – | -105.1% | +3,286.0% | -11.3% | – | |
| – | +69.9% | -26.3% | -176.2% | – | – | – | -120.7% | – | -354.9% | – | – | – | |
| – | – | -42.9% | -201.0% | – | – | – | – | – | -413.4% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.